Elixinol Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 2

Elixinol General Information

Description

Manufacturer of hemp-derived wellness products designed for everyday balance. The company utilizes a proprietary extraction process to preserve cannabinoids and terpenes, providing individual consumers with CBD oils, gummies, capsules, topicals, hemp extracts, and delta-9 gummies to support natural health.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7173 South Havana Street
  • Suite 600-352
  • Centennial, CO 80020
  • United States
+1 (844)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Consumer Non-Durables
Parent Company
Ananda Health
Corporate Office
  • 7173 South Havana Street
  • Suite 600-352
  • Centennial, CO 80020
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elixinol Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Elixinol‘s full profile, request access.

Request a free trial

Elixinol Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of hemp-derived wellness products designed for everyday balance. The company utilizes a proprietary extract
Other Pharmaceuticals and Biotechnology
Centennial, CO
9 As of 2017

Toronto, Canada
 

Newtown, Australia
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elixinol Competitors (3)

One of Elixinol’s 3 competitors is Trubar, a Corporate Backed or Acquired company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Trubar Corporate Backed or Acquired Toronto, Canada
Hemp Foods Australia Corporation Newtown, Australia
Medterra CBD Private Equity-Backed Irvine, CA
You’re viewing 3 of 3 competitors. Get the full list »

Elixinol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elixinol Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Elixinol‘s full profile, request access.

Request a free trial

Elixinol Investments (2)

Elixinol’s most recent deal was a Corporate with Altmed Pets for . The deal was made on 24-Apr-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Altmed Pets 24-Apr-2019 Corporate Other Consumer Non-Durables
Northern Colorado High Plains Producers 24-Apr-2018 Joint Venture Cultivation
To view Elixinol’s complete investments history, request access »

Elixinol Exits (1)

Elixinol’s most recent exit was on 24-Apr-2019 from Altmed Pets. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Altmed Pets 24-Apr-2019 Completed
To view Elixinol’s complete exits history, request access »

Elixinol FAQs

  • When was Elixinol founded?

    Elixinol was founded in 2014.

  • Where is Elixinol headquartered?

    Elixinol is headquartered in Centennial, CO.

  • What is the size of Elixinol?

    Elixinol has 9 total employees.

  • What industry is Elixinol in?

    Elixinol’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Elixinol a private or public company?

    Elixinol is a Private company.

  • What is the current valuation of Elixinol?

    The current valuation of Elixinol is .

  • What is Elixinol’s current revenue?

    The current revenue for Elixinol is .

  • Who are Elixinol’s investors?

    Elixinol Wellness has invested in Elixinol.

  • Who are Elixinol’s competitors?

    Trubar, Hemp Foods Australia, and Medterra CBD are competitors of Elixinol.

  • When was Elixinol acquired?

    Elixinol was acquired on 04-Sep-2026.

  • Who acquired Elixinol?

    Elixinol was acquired by Ananda Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process